RD

Active Director Director DIN 00951003
DIN 00951003 First appointment Jul 2004 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2004
Shareholding value •••• Premium profile

About Rajib Dey

Data last updated:

Rajib Dey is a Director at Medisphere Biotech India Private Limited (since 2004). The company operates in Healthcare. Medisphere Biotech India Private Limited reported revenue of ₹4.83 Cr (FY 2025).

DIN 00951003
Primary Designation Director
Industry Healthcare
First Appointment 23 Jul 2004
Oldest Company Age 22 yrs
Largest company Medisphere Biotech India Private Limited · ₹4.83 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Jul 20042004₹4.83 Cr (FY 2025)Active

Board colleagues of Rajib Dey

NameDINCompanyDesignation
Swikriti Dey00894577Medisphere Biotech India Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medisphere Biotech India Private Limited
Premium access

Shareholding and investment profile for Rajib Dey

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajib Dey

Rajib Dey currently holds 1 directorship: Medisphere Biotech India Private Limited (Director, since 23 Jul 2004, revenue ₹4.83 Cr (FY 2025)).

Rajib Dey was first appointed on 23 Jul 2004 as Director at Medisphere Biotech India Private Limited.

The current boards of Rajib Dey's companies include Swikriti Dey (Medisphere Biotech India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available